Israeli startup Aidoc, which developed artificial intelligence (AI) for medical imaging, announced today a $66 million investment, led by General Catalyst.
This Series C financing, bringing the company’s total capital to more than $140 million, follows a rise in demand for Aidoc’s solutions, including the largest clinical deployment of AI in healthcare via its relationship with Radiology Partners.
Founded in 2016 by Michael Braginsky, Elad Walach, and Guy Reiner, Aidoc assists medical specialists in identifying acute irregularities in real-time. It has developed FDA-cleared artificial intelligence-based technologies that evaluate medical pictures for urgent conditions and generate alerts directly within the imaging workflow, thereby expediting treatment and improving overall patient quality of care. The company’s healthcare artificial intelligence platform is presently being used by radiologists in health networks, hospitals, and radiology groups worldwide and has evaluated over 8 million cases to date.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at email@example.com.
“This investment follows important milestones, including the expansion of our product lines, tripling our FDA certifications, and quadrupling our customer base,” said Elad Walach, co-founder and CEO of Aidoc. “We are undergoing rapid growth, which is also a direct outcome of C-level executives embracing an AI approach and integrating our platform as a required solution throughout therapeutic pathways. It’s an incredible privilege – and a tremendous duty – to be the trusted partner of the world’s most creative health systems and medical practices.”